CD4 and triple-negative breast carcinoma: Significantly, we found that systemic administrationof SLR-LNPs reprogrammed the breast TME to enhance the infiltrationof CD8+ and CD4+ T cells with antitumor function,resulting in enhanced response to αPD-1 ICI in an orthotopicEO771 model of triple-negative breast cancer.